128 related articles for article (PubMed ID: 18234283)
1. Low p53 and retinoblastoma protein expression in cervical intraepithelial neoplasia grade 3 lesions is associated with coexistent adenocarcinoma in situ.
Kruse AJ; Skaland I; Munk AC; Janssen E; Gudlaugsson E; Baak JP
Hum Pathol; 2008 Apr; 39(4):573-8. PubMed ID: 18234283
[TBL] [Abstract][Full Text] [Related]
2. The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2-3.
Ovestad IT; Gudlaugsson E; Skaland I; Malpica A; Munk AC; Janssen EA; Baak JP
J Clin Pathol; 2011 Apr; 64(4):303-7. PubMed ID: 21421698
[TBL] [Abstract][Full Text] [Related]
3. Combined p53 and retinoblastoma protein detection identifies persistent and regressive cervical high-grade squamous intraepithelial lesions.
Baak JP; Kruse AJ; Garland SM; Skaland I; Janssen EA; Tabrizi S; Fagerheim S; Robboy S; Nilsen ST
Am J Surg Pathol; 2005 Aug; 29(8):1062-6. PubMed ID: 16006801
[TBL] [Abstract][Full Text] [Related]
4. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
Zhang G; Yang B; Abdul-Karim FW
Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia.
Tringler B; Gup CJ; Singh M; Groshong S; Shroyer AL; Heinz DE; Shroyer KR
Hum Pathol; 2004 Jun; 35(6):689-96. PubMed ID: 15188135
[TBL] [Abstract][Full Text] [Related]
6. Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity.
Howitt BE; Nucci MR; Drapkin R; Crum CP; Hirsch MS
Am J Surg Pathol; 2013 Jan; 37(1):89-97. PubMed ID: 23211296
[TBL] [Abstract][Full Text] [Related]
7. Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.
Castle PE; Adcock R; Cuzick J; Wentzensen N; Torrez-Martinez NE; Torres SM; Stoler MH; Ronnett BM; Joste NE; Darragh TM; Gravitt PE; Schiffman M; Hunt WC; Kinney WK; Wheeler CM; ;
Arch Pathol Lab Med; 2020 Jun; 144(6):725-734. PubMed ID: 31718233
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expressions of p16 and p53 proteins in cervical intraepithelial neoplasia and in benign cervical tissue.
Tosun G; Sendag F; Zeybek B; Cosan Terek M; Guven C; Zekiogly O; Bilgin O
Eur J Gynaecol Oncol; 2010; 31(6):627-31. PubMed ID: 21319504
[TBL] [Abstract][Full Text] [Related]
9. p53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus virus DNA-positive cervical intraepithelial neoplasia and invasive cancer.
Amortegui AJ; Meyer MP; Elborne VL; Amin RM
Mod Pathol; 1995 Dec; 8(9):907-12. PubMed ID: 8751330
[TBL] [Abstract][Full Text] [Related]
10. Superficial (early) endocervical adenocarcinoma in situ: a study of 12 cases and comparison to conventional AIS.
Witkiewicz A; Lee KR; Brodsky G; Cviko A; Brodsky J; Crum CP
Am J Surg Pathol; 2005 Dec; 29(12):1609-14. PubMed ID: 16327433
[TBL] [Abstract][Full Text] [Related]
11. [The morphological and immunohistochemical characteristics of stratified mucin-producing intraepithelial lesion].
Shamarakova MV; Asaturova AV; Ezhova LS; Dumanovskaya MR; Faizullina NM; Kozachenko AV
Arkh Patol; 2017; 79(5):16-20. PubMed ID: 29027524
[TBL] [Abstract][Full Text] [Related]
12. [Association of p16, p53, Ki-67 expressions with high-risk human papilloma virus infection in cervical intraepithelial neoplasia].
Shi J; Zheng JS; Yin F; Hu WW; Huang XJ; Zhou XL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):515-7. PubMed ID: 17545048
[TBL] [Abstract][Full Text] [Related]
13. Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm.
Tsuda H; Hashiguchi Y; Nishimura S; Kawamura N; Inoue T; Yamamoto K
Gynecol Oncol; 2003 Dec; 91(3):476-85. PubMed ID: 14675665
[TBL] [Abstract][Full Text] [Related]
14. Value of p16(INK4a) and Ki-67 Immunohistochemical Staining in Cervical Intraepithelial Neoplasia Grade 2 Biopsies as Biomarkers for Cervical Intraepithelial Neoplasia Grade 3 in Cone Results.
Miralpeix E; Solé-Sedeño JM; Mancebo G; Lloveras B; Bellosillo B; Carreras R; Alameda F
Anal Quant Cytopathol Histpathol; 2016 Feb; 38(1):1-8. PubMed ID: 27363060
[TBL] [Abstract][Full Text] [Related]
15. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
[TBL] [Abstract][Full Text] [Related]
16. Cytology and curetting diagnosis of endocervical adenocarcinoma.
Bruehl FK; Dyhdalo KS; Hou Y; Clapacs E; Przybycin CG; Reynolds JP
J Am Soc Cytopathol; 2020; 9(6):556-562. PubMed ID: 32624383
[TBL] [Abstract][Full Text] [Related]
17. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
[TBL] [Abstract][Full Text] [Related]
18. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
[TBL] [Abstract][Full Text] [Related]
19. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM
Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662
[TBL] [Abstract][Full Text] [Related]
20. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Lehtinen M; Paavonen J; Wheeler CM; Jaisamrarn U; Garland SM; Castellsagué X; Skinner SR; Apter D; Naud P; Salmerón J; Chow SN; Kitchener H; Teixeira JC; Hedrick J; Limson G; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; De Carvalho NS; Germar MJ; Peters K; Mindel A; De Sutter P; Bosch FX; David MP; Descamps D; Struyf F; Dubin G;
Lancet Oncol; 2012 Jan; 13(1):89-99. PubMed ID: 22075171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
